| Title | Regenerative Medicine Market worth $49.0 billion by 2028 |
|---|
| URL | https://www.openpr.com/news/3538206/regenerative-medicine-market-size-share-trends-2028 |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Global Regenerative Medicine Market, Regenerative Medicines Industry, Regenerative Medicine Market Size, Global Regenerative Medicine Market Trends |
|---|
| Meta Description | Novartis AG (Switzerland), Biogen, Inc. (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen Inc. (US), Smith+Nephew (UK), MEDIPOST Co., Ltd. (Korea), |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The Global Regenerative Medicine Market in terms of revenue was estimated to be worth $16.0 Billion in 2023 and is poised to reach $49.0 Billion by 2028, growing at a CAGR of 25.1% from 2023 to 2028. |
